MOKAN Wealth Management Inc.
Source: SEC Form 13F · as of Mar 2026MOKAN Wealth Management Inc. holds 13 biotech & pharma companies tracked by BioSniper, totaling $20.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$20.0M
| Company | Shares | Value |
|---|---|---|
| MRKMerck & Co., Inc. | 42,942 | $5.2M |
| ABBVAbbVie Inc. | 19,167 | $4.2M |
| LLYELI LILLY & Co | 4,079 | $3.8M |
| ABTABBOTT LABORATORIES | 13,361 | $1.4M |
| JNJJOHNSON & JOHNSON | 4,110 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 5,479 | $763K |
| UTHRUNITED THERAPEUTICS Corp | 1,131 | $670K |
| ZTSZoetis Inc. | 5,560 | $658K |
| NBIXNEUROCRINE BIOSCIENCES INC | 4,585 | $604K |
| ELANElanco Animal Health Inc | 25,177 | $602K |
| MMSIMerit Medical Systems Inc. | 7,844 | $541K |
| HALOHALOZYME THERAPEUTICS, INC. | 7,601 | $491K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 785 | $213K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.